Aroa Biosurgery Limited

Equities

ARX

NZARXE0001S1

Medical Equipment, Supplies & Distribution

Delayed Australian S.E. 00:39:31 2024-06-27 EDT 5-day change 1st Jan Change
0.585 AUD -0.85% Intraday chart for Aroa Biosurgery Limited -4.10% -29.52%
Chart Aroa Biosurgery Limited
More charts
Aroa Biosurgery Limited is a soft-tissue regeneration company. It develops, manufactures, sells, distributes medical and surgical products to improve healing in complex wounds and soft tissue reconstruction. Its products are developed from the AROA extracellular matrix (ECM) technology platform, an extracellular matrix biomaterial derived from ovine forestomach. AROA ECM is an ECM biomaterial containing a rich and complex mix of biological molecules that is the building block for a range of soft tissue repair products. Its products include Endoform, Myriad Matrix, Myriad Morcells, Myriad Morcells Fine, Symphony and Reinforced Bioscaffolds. Endoform products support all phases of wound healing and are appropriate for use early in wound management to restore protease balance and advance healing to the proliferative phase. Myriad Matrix is an engineered ECM for soft tissue repair, reinforcement, and complex wounds.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
0.6451 NZD
Average target price
1.076 NZD
Spread / Average Target
+66.74%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. ARX Stock
  4. News Aroa Biosurgery Limited
  5. Aroa Biosurgery Says ENIVO System Showed Potential in Reduction of Post-Surgical Complication